Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

amantadine

amantadine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Gocovri CAPSULE, EXTENDED RELEASE, ORAL 68.5 mg, 137 mg    
Symmetrel CAPSULE, ORAL 100 mg      
Symmetrel SYRUP, ORAL 50 mg/5 mL      
Osmolex ER TABLET, EXTENDED RELEASE, ORAL 129 mg, 193 mg, 258 mg    
VIEW MORE Adamantanes, Central Nervous System Agents, Miscellaneous
CLASS
081804, 289200
Comments:
Ordered Formulation Therapeutic Interchange

amantadine (Gocovri)

  • 68.5 mg once daily

amantadine

  • If CrCl: 30-60 mL/min
    • 100 mg once daily
  • If CrCl: 15-29 mL/min
    • 100 mg once every other day

 

amantadine (Gocovri)

  • 137 mg once daily
  • 274 mg once daily

amantadine

  • 100 mg BID
  • 100 mg TID

amantadine (Osmolex ER)

  • 129 mg once daily
  • 193 mg once daily
  • 258 mg once daily
  • 322 mg once daily

amantadine

  • 100 mg (daily)
  • 200 mg (100 mg BID)
  • 300 mg (100 mg TID)
  • 300 mg (100 mg TID)

Gocovri is non-formulary, not stocked. Automatic interchange to IR amantadine.

Osmolex ER is non-formulary, not stocked. Automatic interchange to IR amantadine.

Reviewed: 22 May 2018 (Gocovri), and 27 Nov 2018 (Osmolex ER)

Last updated: Dec. 5, 2018






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved